ATE552891T1 - Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung - Google Patents

Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung

Info

Publication number
ATE552891T1
ATE552891T1 AT04024815T AT04024815T ATE552891T1 AT E552891 T1 ATE552891 T1 AT E552891T1 AT 04024815 T AT04024815 T AT 04024815T AT 04024815 T AT04024815 T AT 04024815T AT E552891 T1 ATE552891 T1 AT E552891T1
Authority
AT
Austria
Prior art keywords
acid
zymes
combination
buffer solutions
protease
Prior art date
Application number
AT04024815T
Other languages
English (en)
Inventor
Scott J Norton
Glen Gillis
Michael Bishop
Original Assignee
Active Organics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Organics Inc filed Critical Active Organics Inc
Application granted granted Critical
Publication of ATE552891T1 publication Critical patent/ATE552891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT04024815T 1996-06-13 1997-06-13 Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung ATE552891T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/664,056 US5976556A (en) 1996-06-13 1996-06-13 Combination of acid protease enzymes and acidic buffers and uses thereof

Publications (1)

Publication Number Publication Date
ATE552891T1 true ATE552891T1 (de) 2012-04-15

Family

ID=24664334

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04024815T ATE552891T1 (de) 1996-06-13 1997-06-13 Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung
AT97930044T ATE284670T1 (de) 1996-06-13 1997-06-13 Kombination von saurer protease-enzyme und saure puffers und ihre verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97930044T ATE284670T1 (de) 1996-06-13 1997-06-13 Kombination von saurer protease-enzyme und saure puffers und ihre verwendung

Country Status (11)

Country Link
US (2) US5976556A (de)
EP (2) EP1598057B1 (de)
JP (2) JP4681087B2 (de)
KR (1) KR20000016635A (de)
AT (2) ATE552891T1 (de)
AU (1) AU3396597A (de)
DE (1) DE69731955T2 (de)
DK (1) DK0921785T3 (de)
ES (2) ES2383682T3 (de)
PT (1) PT921785E (de)
WO (1) WO1997047283A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof
WO1998048775A1 (en) * 1997-02-12 1998-11-05 Johnson & Johnson Consumer Companies, Inc. Serine protease and topical retinoid compositions
FR2761363B1 (fr) * 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
EP1049424A4 (de) * 1998-01-06 2001-11-28 Nicholas A Sceusa Arzneidosierung basierend auf dem teorell-mayer-gradienten
US6210693B1 (en) * 1998-02-10 2001-04-03 Shiseido Company, Ltd. Oil-in-water type emulsified composition
FR2777185B1 (fr) * 1998-04-08 2001-03-16 Serobiologiques Lab Sa Composition cosmetique et/ou pharmaceutique pour le traitement des rides et procede de traitement mettant en oeuvre cette composition
US6656701B2 (en) * 1999-07-16 2003-12-02 Actim Organics, Inc Combination of acid protease enzymes and acidic buffers and uses thereof
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
DE10042576B4 (de) * 2000-08-15 2004-08-12 Coty B.V. Kosmetischer Basiskomplex und dessen Verwendung
JP2002284665A (ja) * 2001-03-23 2002-10-03 Nippon Hypox Lab Inc 化粧料
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
US20030021775A1 (en) * 2001-07-27 2003-01-30 Ramot University Authority For Applied Research & Industrial Development Ltd. Device for and method of controlled enzymatic removal and retrieval of tissue
US6858215B2 (en) * 2002-06-14 2005-02-22 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US6835385B2 (en) * 2002-06-14 2004-12-28 Carol J. Buck Compositions and methods for softening, thinning and removing hyperkeratotic tissue
US20060013786A1 (en) * 2002-07-02 2006-01-19 Noevir Co., Ltd Skin preparation for external use
WO2004017972A1 (en) * 2002-08-23 2004-03-04 Law Peter K Biologic skin repair and enhancement
US20050129615A1 (en) * 2003-10-09 2005-06-16 Jacek Rozga Non-invasive system for detecting skin cancer
US20070244195A1 (en) * 2004-05-18 2007-10-18 Burkhart Craig N Treatment methods with peroxides and tertiary amines
EP1824972A2 (de) * 2004-12-09 2007-08-29 Dow Global Technologies Inc. Enzymstabilisierung
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20070027152A1 (en) * 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
JP2007145931A (ja) * 2005-11-25 2007-06-14 Ecobio 動物用耳穴洗浄剤
US7776339B2 (en) * 2006-01-11 2010-08-17 Active Organics, Lp Extract of R. miehei
US20070264222A1 (en) * 2006-05-10 2007-11-15 Biohealth Advance, Llc Enhanced protection against skin injury in humans
FR2909554B1 (fr) * 2006-12-08 2013-11-01 Biorecept Lab Composition cosmetique anti-rides comprenant de l'acide hyaluronique
US7381433B1 (en) 2007-01-08 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Compositions containing an extract of a primula denticulata and use thereof
EP2011471A1 (de) * 2007-07-02 2009-01-07 Johnson & Johnson Consumer France SAS Schäumende Ölzubereitungen
US7854936B2 (en) * 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
KR20130116386A (ko) 2008-04-14 2013-10-23 할로자임, 아이엔씨 히알루로난 관련 질환 및 상태 치료용 변형된 히알루로니다제 및 그 용도
FR2930727B1 (fr) * 2008-04-30 2012-10-05 Evolution Dermatologique Lab Composition pour le traitement des etats seborrheiques.
ITTO20080579A1 (it) * 2008-07-28 2010-01-29 Chiara Cesano Composizione per la rigenerazione di tessuto ipertrofico, relativi prodotti ed usi
EP2403523A1 (de) * 2009-03-06 2012-01-11 Halozyme, Inc. Temperaturempfindliche mutanten von matrix metalloprotease 1 und ihre verwendungen
CN102471766A (zh) * 2009-07-17 2012-05-23 科洛普拉斯特公司 带有酶的粘性贴片
EP2316436A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Film, insbesondere einem löslichen Film, mit mindestens einem Enzym
EP2316438A1 (de) 2009-10-30 2011-05-04 Johnson & Johnson GmbH Band, insbesondere Klebeband zur Behandlung von Hauterkrankungen mit mindestens einem Hyperkeratosehemmer und/oder mindestens einem keratinolytischem Wirkstoff
US20110152384A1 (en) * 2009-12-17 2011-06-23 Gunn Euen T Mild leave-on skin care compositions
EP2340803A1 (de) * 2009-12-30 2011-07-06 Brands Asia Pacific Limited Zusammensetzung zum Entfernen abgestorbener Hautzellen und Pad für Hände und Füße enthaltend besagte Zusammensetzung
WO2012095702A1 (en) * 2011-01-13 2012-07-19 Medestea Internazionale S.P.A. A composition for the regeneration of atrophic tissues
WO2012154903A1 (en) 2011-05-10 2012-11-15 Active Organics, Inc. Compositions containing extracts of mucor miehei and mucor rouxii
FR2984725B1 (fr) * 2011-12-26 2014-01-31 Achaladanelle Utilisation d'une composition cosmetique ou dermocosmetique pour lutter contre les effets du tabac sur la peau
WO2014107745A1 (en) 2013-01-07 2014-07-10 Halozyme, Inc. Metal sensitive mutants of matrix metalloproteases and uses thereof
KR101531479B1 (ko) * 2014-11-21 2015-06-26 세원셀론텍(주) 의료용 재료로 사용하기 위한 고농도 콜라겐 제조방법
WO2016105499A1 (en) 2014-12-23 2016-06-30 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
KR102078140B1 (ko) * 2015-03-13 2020-02-17 주식회사 엘지생활건강 ｐＨ 완충 시스템을 갖는 유화 화장료 조성물
KR101865764B1 (ko) * 2017-01-13 2018-06-11 주식회사 아미코스메틱 천연 복합 추출물 및 미세침 분말을 유효성분으로 포함하는 각질 박리용 화장료 조성물
EP3681479B1 (de) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Natriumhydrogencarbonat zur verwendung in der behandlung von gicht und verwandten erkrankungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU439288A1 (ru) * 1971-07-29 1974-08-15 Республиканский Ожоговый Центр При Грьковском Научно-Исследовательском Институте Травматологии И Ортопедии Средство дл растворени некротизированных тканей
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
JPS60215621A (ja) * 1984-04-12 1985-10-29 Kao Corp 弱酸性入浴剤
US5431913A (en) * 1992-01-24 1995-07-11 Phillips; Eva J. Skin cleansing and exfoliant composition and method of treating skin
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
US5516517A (en) * 1994-05-02 1996-05-14 Exfoliation Cleansing Hydration Oxygenation Corporation Method for nutritional oxygenation of the skin
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof

Also Published As

Publication number Publication date
EP0921785A1 (de) 1999-06-16
JP2007302680A (ja) 2007-11-22
DE69731955T2 (de) 2005-12-22
JP2000512298A (ja) 2000-09-19
DK0921785T3 (da) 2005-04-18
EP1598057B1 (de) 2012-04-11
WO1997047283A1 (en) 1997-12-18
ES2383682T3 (es) 2012-06-25
DE69731955D1 (de) 2005-01-20
PT921785E (pt) 2005-05-31
AU3396597A (en) 1998-01-07
US6569437B1 (en) 2003-05-27
EP0921785B1 (de) 2004-12-15
EP1598057A1 (de) 2005-11-23
ATE284670T1 (de) 2005-01-15
ES2235239T3 (es) 2005-07-01
KR20000016635A (ko) 2000-03-25
JP4681087B2 (ja) 2011-05-11
US5976556A (en) 1999-11-02
EP0921785A4 (de) 2002-02-13

Similar Documents

Publication Publication Date Title
ATE552891T1 (de) Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
BR9710993A (pt) Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als)
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
FR2710527B1 (fr) Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
BR9506820A (pt) Derivados de 4-amino de ácido micofenólico
BRPI0015533B8 (pt) enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação
ATE234108T1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
DE59406374D1 (de) Hydroxamsäuren und hydroxamsäureether sowie ihre verwendung als komplexbildner
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
ES2195000T3 (es) Composicion farmaceutica.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
LV12149A (lv) 5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
DE69524388D1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
AU2253197A (en) Novel substituted N-Methyl-N-(4-(4-(1H-benzimidazol- 2-yl){1,4}diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
DE69824670D1 (de) TCF-II für Vorbeugung und/oder Behandlung von strahlungsinduzierter Störungen
ATE230799T1 (de) Verkürzte, menschliche cholesterol-7-alpha- hydroxylase, verfahren zur dessen herstellung und deren verwendung
WO1999011249A3 (en) Use of endipalene in the treatment of psoriasis